Harlan Pinto - Concepedia

Concepedia

Author

Harlan Pinto

Stanford University ORCID

Also Known As

H PINTO, H Pinto, H. Marques Pinto, H. Pinto, Harlan Pinto, Hudson Pereira Pinto, Jori Hardin, Mitchell Posner

46

Publications

3.8K

Citations

15

H-Index

31

Concepts

All Affiliations

Stanford University Stanford Medicine Johns Hopkins University Dana-Farber Cancer Institute VA Palo Alto Health Care System

HP

About

Harlan Pinto is an author at Stanford University specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	450
2	Health Sciences	3	3	239
3	Pathology	2	2	39
4	Gastroenterology	1	1	16
5	Pharmacology	1	1	14

Harlan Pinto

×

17

Publications

3.8K

Citations

15

H-Index

	Year	Citations
Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical Trial Carole Fakhry, William H. Westra, S. Li, JNCI Journal of the National Cancer Institute	2008	2.8K
Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology Group Study E2399 Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Journal of Clinical Oncology	2007	145
Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms Catherine K. Su, Vivek Mehta, Lavanya Ravikumar, International Journal of Radiation OncologyBiologyPhysics Radiation TherapyMedicinePhase Ii Double-blindHead And Neck CancerHead And Neck Squamous Cell Carcinoma	2004	126
Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure Megan E. Daly, Quynh‐Thu Le, Peter G. Maxim, International Journal of Radiation OncologyBiologyPhysics Adaptive RadiotherapyRadiation TherapyMedicineRadionuclide TherapyOropharyngeal Cancer	2009	119
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Andrew Quon, Nancy J. Fischbein, I. Ross McDougall, PubMed Oncologic ImagingSquamous Cell CarcinomaPet-mriPositron Emission Tomography18F-fdg Pet/ct	2007	104
Recruiting Minority Cancer Patients Into Cancer Clinical Trials: A Pilot Project Involving the Eastern Cooperative Oncology Group and the National Medical Association Worta McCaskill‐Stevens, Harlan Pinto, Alfred C. Marcus, Journal of Clinical Oncology	1999	103
Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma Megan E. Daly, Y.C Lieskovsky, Todd Pawlicki, Head & Neck	2006	90
Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma: impact on local control David J. Tate, John R. Adler, Steven D. Chang, International Journal of Radiation OncologyBiologyPhysics	1999	80
Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer Kenneth J. Chang, Tony Reid, Neil Senzer, Gastrointestinal Endoscopy Surgical OncologyEsophagusEsophageal CancerGastrointestinal OncologyMedicine	2012	46
Concurrent cetuximab versus platinum-based chemoradiation for the definitive treatment of locoregionally advanced head and neck cancer Chad Tang, Cato Chan, Wen Jiang, Head & Neck	2014	39

Page 1